White, Michel

Enalapril Reduces the Incidence of Diabetes in Patients With Chronic Heart Failure: Insight From the Studies Of Left Ventricular Dysfunction (SOLVD)

Vermes, E., Ducharme, A., Bourassa, M. G., Lessard, M., White, M., & Tardif, J.-C. (2003) · Circulation

Heart Failure Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 248

Care Gaps in Adherence to Heart Failure Guidelines

Jarjour, M., Henri, C., de Denus, S., Fortier, A., Bouabdallaoui, N., Nigam, A., O’Meara, E., Ahnadi, C., White, M., Garceau, P., et al. (2020) · JACC: Heart Failure

Heart Failure Treatment and ManagementCardiac pacing and defibrillation studies

Cited by 105

Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial

Bowling, C. B., Sanders, P. W., Allman, R. M., Rogers, W. J., Patel, K., Aban, I. B., Rich, M. W., Pitt, B., White, M., Bakris, G. C., et al. (2013) · International Journal of Cardiology

Heart Failure Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 85

Renin-angiotensin system inhibition and lower 30-day all-cause readmission in Medicare beneficiaries with heart failure

Sanam, K., Bhatia, V., Bajaj, N. S., Gaba, S., Morgan, C. J., Fonarow, G. C., Butler, J., Deedwania, P., Prabhu, S. D., Wu, W.-C., et al. (2016) · The American Journal of Medicine

Heart Failure Treatment and ManagementRenin-Angiotensin System Studies

Cited by 50

Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])

Carson, P., Fiuzat, M., O'Connor, C., Anand, I., Plehn, J., Lindenfeld, J. A., Silver, M., White, M., Miller, A., Davis, G., et al. (2010) · American Heart Journal

Heart Failure Treatment and ManagementStatistical Methods in Clinical Trials

Cited by 31

Neutrophils and circulating inflammatory biomarkers in diabetes mellitus and heart failure with preserved ejection fraction

Chaar, D., Dumont, B. L., Vulesevic, B., Neagoe, P.-E., Räkel, A., White, M., & Sirois, M. G. (2022) · The American Journal of Cardiology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 22

Growth Differentiation Factor-15 as a Predictor of Functional Capacity, Frailty, and Ventricular Dysfunction in Patients With Aortic Stenosis and Preserved Left Ventricular Ejection Fraction

Basmadjian, L., Bouabdallaoui, N., Simard, F., O'Meara, E., Ducharme, A., Rouleau, J.-L., Racine, N., White, M., Sirois, M. G., Asgar, A., et al. (2023) · The American Journal of Cardiology

GDF15 and Related BiomarkersCardiac Valve Diseases and Treatments

Cited by 6